Filter
908
Text search:
MDR-TB
Featured
Recommendations
91
New Publications
243
Language
Document type
No document type
688
Studies & Reports
76
Guidelines
66
Manuals
20
Strategic & Response Plan
19
Fact sheets
15
Situation Updates
14
Training Material
7
Infographics
2
Resource Platforms
1
Countries / Regions
Western and Central Europe
62
Eastern Europe
47
India
36
South Africa
23
Kenya
22
Namibia
17
Ukraine
17
Tanzania
16
Nepal
15
Malawi
15
Myanmar / Burma
15
Ethiopia
14
Bangladesh
14
Zambia
13
Uganda
12
Rwanda
12
Latin America and the Carribbean
12
Asia
12
Cambodia
11
Lesotho
9
South–East Asia Region
9
Russia
9
Liberia
8
Nigeria
8
Ghana
8
Indonesia
7
Botswana
7
Global
7
Sierra Leone
6
Mozambique
6
Philippines
5
Germany
5
Colombia
5
Tajikistan
5
Senegal
4
Zimbabwe
4
Guinea
3
Congo, Democratic Republic of
3
Benin
3
Argentina
3
Peru
3
Eswatini/ Swaziland
3
Bhutan
3
Armenia
3
Timor Leste/ East Timor
3
Georgia
3
Burkina Faso
2
Pakistan
2
Central African Republic
2
Madagascar
2
Sri Lanka
2
Paraguay
2
Venezuela
2
Albania
2
Moldova
2
Vietnam
2
Cameroon
1
Somalia
1
South Sudan
1
Afghanistan
1
Gambia
1
El Salvador
1
Bolivia
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Africa
1
North Korea
1
Estonia
1
Kazakhstan
1
Turkmenistan
1
Maldives
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
321
Clinical Guidelines
84
Public Health
28
Key Resources
10
Capacity Building
8
Women & Child Health
7
Pharmacy & Technologies
7
Toolboxes
TB
502
HIV
80
AMR
34
Polio
20
Refugee
14
NTDs
10
Conflict
8
Ebola & Marburg
7
Global Health Education
7
Pharmacy
7
Rapid Response
4
COVID-19
4
Caregiver
4
Health Financing Toolbox
3
Disability
2
Natural Hazards
2
Mental Health
2
NCDs
2
2.0 Rapid Response
2
Specific Hazards
1
Planetary Health
1
International Journal of Drug Policy 24 (2013) e91-98
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al
...
Hacia respuestas al VIH y a la tuberculosis que transformen las relaciones de género
Guía para países de bajos ingresos. 2 edición
Ciudad de México, México - 26 al 28 de mayo del 2014
Towards gender - transformative HIV and TB responses
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
The Journal of Infection in Developing Countries 7(3):289-292
The Anglophone Africa Civil Society and Communities CCM Shadow Report and Scorecard Initiative
Chapter 8, Prison and Health, published
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Accessed November 2017